1,226 results on '"Flentje, Michael"'
Search Results
52. Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status
53. Salvage-Bestrahlung der Prostataloge
54. “Radiation Effects” in Patient Treatment
55. Dosimetric evaluation of a spinal cord dose‐limiting 3D‐CRT technique for radiotherapy of spinal metastases.
56. Hypofractionated radiotherapy for localized prostate cancer
57. GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer
58. Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era
59. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer
60. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer
61. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including Acetazolamide in human Glioblastoma
62. Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines
63. Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule
64. Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity
65. Dosimetric Evaluation of Commercially Available Flat vs. Self-Produced 3D-Conformal Silicone Boluses for the Head and Neck Region
66. Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up
67. Ultrahypofractionation of localized prostate cancer
68. Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
69. Nasenhöhle und Nasennebenhöhlen
70. Radiation Nephritis
71. Dosimetric evaluation of a spinal cord dose-limiting 3D-CRT technique for radiotherapy of spinal metastases
72. Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer
73. Additional file 3 of PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy
74. Additional file 1 of Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
75. Additional file 3 of Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
76. Additional file 1 of PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy
77. Additional file 4 of Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
78. Desynchronization of Cartesian k‐space sampling and periodic motion for improved retrospectively self‐gated 3D lung MRI using quasi‐random numbers
79. Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases
80. Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer: Results of a Phase I Study
81. Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose
82. Dose–response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy
83. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer
84. Health-Related Quality Of Life And Clinical Outcome After Radiotherapy of Patients With Intracranial Meningioma
85. O-(2-[18F]fluoroethyl)-l-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy
86. An Interlaced IMRT Technique for Elongated Tumor Volumes
87. Steep dose gradients for simultaneous integrated boost IMRT
88. Is ad-hoc plan adaptation based on 2-Step IMRT feasible?
89. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?
90. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy
91. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: Importance of baseline symptoms and of prostate-V150
92. Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
93. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases
94. The Effect of Hyperthermia on Hemopoietic Progenitor Cells of the Mouse
95. Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy
96. PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma
97. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme
98. kV Cone-Beam CT-Based IGRT: A Clinical Review
99. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro
100. Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.